# Yuanqi Pharmaceutical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/yuanqi-pharmaceutical

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Total disclosed funding: $15M
- Latest round: Angel (Mar 26, 2021)
- Investors on record: 3

## About

Established in 2020 and based in Suzhou, China, Yuanqi Pharmaceutical is a biopharmaceutical company that focused on drug Discovery. In 2021, it raised approximately RMB 100 million in angel funding from Anlongmed Investment, Bohe Angel Fund and Kaitai Capital.

The company engages in developing target drugs based on target structure research technology and artificial intelligence technology. The target drug includes GPCR (G Protein-Coupled Receptors) drug.

The company’s revenue is generated by selling drugs to customers.

## Funding rounds

- Angel, Mar 26, 2021, $15M — Kaitai Capital, AnlongMed Investment, Bohe Angel Fund

## Investors

- Kaitai Capital (https://capitalatlas.ai/funds/kaitai-capital) — Angel
- AnlongMed Investment — Angel
- Bohe Angel Fund — Angel